发明名称 ARYLAMIDES
摘要 The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection. In a specific embodiment, the invention relates to a compound of the formula (see formula I) in which R1 is heteroaryl, etc, where heteroaryl can be substituted by 0, 1, 2 or 3 substituents R1-1, the substituents R1-1 being selected independently of one another from the group consisting of halogen, alkyl, nitro, etc, R2 is hydrogen or methyl, R3 is hydrogen, hydroxyl, amino, etc, R4 is hydrogen or C1-C3 alkyl, R5 is halogen, trifluoromethyl, trifluoromethoxy, etc, R6 is alkyl, cycloalkyl, etc, n is a number 0, 1, 2 or 3, m is a number 0, 1, 2, 3 or 4, A is aryl or heteroaryl, or a salt thereof, a solvate thereof or a solvate of a salt thereof.
申请公布号 CA2494846(C) 申请公布日期 2012.01.17
申请号 CA20032494846 申请日期 2003.07.28
申请人 BAYER HEALTHCARE AG 发明人 BRUNNER, NINA;FREIBERG, CHRISTOPH;LAMPE, THOMAS;NELL, PETER;NEWTON, BEN;OTTENEDER, MICHAEL;PERNERSTORFER, JOSEF;POHLMANN, JENS;SCHIFFER, GUIDO;SHIMADA, MITSUYUKI;SVENSTRUP, NIELS;ENDERMANN, RAINER
分类号 C07D409/12;A61K31/40;A61K31/4015;A61K31/4025;A61K31/404;A61K31/4155;A61K31/4192;A61K31/423;A61K31/433;A61K31/4439;A61K31/455;A61K31/4709;A61K31/4725;A61K31/5377;A61P31/04;C07D207/40;C07D401/12;C07D403/12;C07D405/12;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/12 主分类号 C07D409/12
代理机构 代理人
主权项
地址